Acorda Therapeutics to Present at the 2015 RBC Capital Markets'...

... products; and, failure to comply with regulatory requirements could result in adverse action by regulatory agencies. ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that Ron Cohen, President and Chief ...

http://ift.tt/1FWZK8z